report_description,report_link,report_date,report_mdufa_period,source,page,table_number,organization,org,program,table_title,metric_type,performance_metric,fy,value,status
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2013,68.29,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2014,69,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2015,69.51,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2016,74.2,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2017,71.73,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2013,41,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2014,49,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2015,37,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2016,56,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2017,52,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2013,60,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2014,62,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2015,64,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2016,85,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2017,80,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2013,86,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2014,87,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2015,88,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2016,89,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2017,88,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2013,89,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2014,89,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2015,90,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2016,90,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2017,90,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2013,82.84,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2014,83.25,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2015,81.67,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2016,80.32,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2017,76.26,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2013,85,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2014,85,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2015,83,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2016,75,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2017,62,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2013,88,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2014,88,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2015,88,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2016,87,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2017,86,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2013,89,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2014,89,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2015,89,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2016,89,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2017,88,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2013,90,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2014,90,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2015,90,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2016,90,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2017,90,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2013,69.86,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2014,69.05,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2015,69.81,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2016,71.36,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2017,71.51,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2013,49,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2014,47,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2015,50,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2016,53,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2017,54,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2013,73,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2014,74,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2015,72,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2016,77,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2017,76,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2013,85,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2014,85,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2015,85,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2016,85,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2017,86,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2013,88,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2014,88,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2015,88,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2016,88,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2017,89,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,double,Average,2013,62.19,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,double,Average,2014,63.12,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,double,Average,2015,58.91,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,double,Average,2016,57.08,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,double,Average,2017,59.03,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2013,35,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2014,30,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2015,29,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2016,28,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2017,28,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2013,56,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2014,58,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2015,56,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2016,53,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2017,55,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2013,78,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2014,79,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2015,72,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2016,70,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2017,76,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2013,88,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2014,88,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2015,81,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2016,81,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2017,83,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,81.05,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,82.4,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,79.92,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,81.55,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,81.61,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,77,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,84,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,76,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,76,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,81,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,87,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,88,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,87,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,87,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,88,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,89,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,89,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,89,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,89,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,89,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,90,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,90,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,90,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,90,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,90,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,71.68,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,71.37,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,75.07,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,74.18,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,75.58,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,50,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,49,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,55,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,55,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,56,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,80,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,80,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,86,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,86,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,86,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,88,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,88,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,89,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,89,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,88,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,90,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,90,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,90,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,90,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,90,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,75.68,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,78.18,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,78.93,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,81.19,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,80.34,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,58,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,60,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,67,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,83,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,80,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,84,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,87,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,87,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,88,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,88,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,88,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,88,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,89,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,89,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,89,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,89,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,90,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,90,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,90,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,90,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,73.88,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,73.19,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,78.9,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,86.61,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,78.08,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,57,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,55,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,59,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,74,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,56,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,79,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,81,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,84,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,87,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,82,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,87,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,87,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,87,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,89,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,87,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,89,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,89,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,89,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,92,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,89,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,76.47,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,80.32,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,75.83,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,76.86,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,79.17,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,60,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,69,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,62,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,58,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,60,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,86,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,88,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,87,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,86,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,87,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,89,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,90,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,89,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,89,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,89,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,90,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,90,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,90,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,90,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,90,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,71.36,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,70.57,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,66.99,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,66.63,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,69.35,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,52,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,51,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,37,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,44,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,51,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,74,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,76,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,60,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,60,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,68,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,86,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,87,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,86,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,85,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,85,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,89,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,89,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,89,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,88,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,88,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,72.98,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,71.48,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,165.82,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,237.41,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,209.87,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,53,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,31,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,56,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,143,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,135,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,84,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,60,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,87,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,211,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,203,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,88,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,87,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,90,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,268,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,214,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,90,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,90,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,310,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,324,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,286,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,58.72,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,61.13,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,63.56,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,68.43,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,69.15,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,30,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,28,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,29,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,48,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,50,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,55,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,58,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,60,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,71,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,71,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,73,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,77,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,82,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,86,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,86,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,84,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,86,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,87,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,88,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,89,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2023,76.91,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,59,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,86,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,89,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,90,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2023,67.38,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,30,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,60,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,87,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,89,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2023,73.1,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,57,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,85,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,88,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,90,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2023,69.8,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,55,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,70,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,85,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,88,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2023,69.76,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,47,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,60,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,88,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,90,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2023,60.72,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,29,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,56,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,76,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,88,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,double,Average,2023,65.39,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,29,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,59,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,87,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,90,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,double,Average,2023,64.1,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,29,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,58,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,84,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,88,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
